PET with fluorodeoxyglucose F 18/computed tomography in the clinical management and patient outcomes of esophageal cancer

Robert M. Kwee, Charles Marcus, Sara Sheikhbahaei, Rathan M. Subramaniam

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

PET with fluorodeoxyglucose F 18/computed tomography (18F-FDG PET/CT) has evolved into an indispensable imaging technique in the management of patients with esophageal cancer. Staging with 18F-FDG PET/CT is strongly associated with overall survival and certain 18F-FDG PET/CT parameters predict patient survival. Current evidence supporting the validity of the use of 18F-FDG PET/CT in the tumor delineation process for radiation treatment planning in patients with esophageal cancer is still limited. It is useful in determining treatment response after neoadjuvant therapy and thereby has an impact on management. 18F-FDG PET/CT plays a role in the diagnosis of recurrent disease in patients with a background of clinical suspicion.

Original languageEnglish (US)
Pages (from-to)197-205
Number of pages9
JournalPET Clinics
Volume10
Issue number2
DOIs
StatePublished - Apr 1 2015

Keywords

  • Computed tomography
  • Esophageal cancer
  • F-Fluorodeoxyglucose
  • Management
  • Positron emission tomography

ASJC Scopus subject areas

  • Radiation
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'PET with fluorodeoxyglucose F 18/computed tomography in the clinical management and patient outcomes of esophageal cancer'. Together they form a unique fingerprint.

  • Cite this